Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy
Open Access
- 29 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1442788
Abstract
The human microbiome is the complex ecosystem consisting of trillions of microorganisms that play a key role in developing the immune system and nutrient metabolism. Alterations in the gut microbiome have been linked to cancer initiation, progression, metastasis, and response to treatment. Accumulating evidence suggests that levels of vitamins and minerals influence the gut environment and may have implications for cancer risk and progression. Bifidobacterium has been reported to reduce the colorectal cancer risk by binding to free iron. Additionally, zinc ions have been shown to activate the immune cells and enhance the effectiveness of immunotherapy. Higher selenium levels have been associated with a reduced risk of several cancers, including colorectal cancer. In contrast, enhanced copper uptake has been implicated in promoting cancer progression, including colon cancer. The interaction between cancer and gut bacteria, as well as dysbiosis impact has been studied in animal models. The interplay between prebiotics, probiotics, synbiotics, postbiotics and gut bacteria in cancer offers the diverse physiological benefits. We also explored the particular probiotic formulations like VSL#3, Prohep, Lactobacillus rhamnosus GG (LGG), etc., for their ability to modulate immune responses and reduce tumor burden in preclinical models. Targeting the gut microbiome through antibiotics, bacteriophage, microbiome transplantation-based therapies will offer a new perspective in cancer research. Hence, to understand this interplay, we outline the importance of micronutrients with an emphasis on the immunomodulatory function of the microbiome and highlight the microbiome’s potential as a target for precision medicine in cancer treatment.Keywords
This publication has 272 references indexed in Scilit:
- ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer ImmunotherapyAdvanced Materials, 2021
- Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis modelApplied Microbiology and Biotechnology, 2020
- Functional Roles of B‐Vitamins in the Gut and Gut MicrobiomeMolecular Nutrition & Food Research, 2020
- Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienolsMolecular Carcinogenesis, 2020
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With CancerJAMA Oncology, 2019
- A mouse model of chronic prostatic inflammation using a human prostate cancer‐derived isolate of Propionibacterium acnesThe Prostate, 2013
- Mechanisms by which selenium influences immune responsesArchivum Immunologiae et Therapiae Experimentalis, 2007
- Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma:Helicobacter pyloriCancer, 1997
- Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc.The EMBO Journal, 1995
- Selenium and the Immune Response: 2. Enhancement of Murine Cytotoxic T-Lymphocyte and Natural Killer Cell Cytotoxicity In VivoJournal of Leukocyte Biology, 1989